Boehringer Ingelheim· @Boehringer · X·· 2025-11-10AI 评分42
AI 导读
#NEWS：我们的在研靶向疗法已获得美国 FDA 的 Commissioner’s National Priority Voucher。 在此了解更多：https://go.boehringer.com/jHe3b #LifeForward #Oncology
正文
#NEWS: Our investigational targeted therapy has been awarded a Commissioner’s National Priority Voucher from the U.S. FDA.
Find out more here: https://go.boehringer.com/jHe3b
#LifeForward #Oncology
来源：Boehringer Ingelheim · x.com